Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect.
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D002860:Chromium Radioisotopes; D003094:Collagen / Q000494:pharmacology; D003871:Dermatan Sulfate / Q000633:toxicity; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology; D006025:Glycosaminoglycans / Q000633:toxicity*; D006470:Hemorrhage / Q000139:chemically induced*; D006493:Heparin / Q000633:toxicity*; D007700:Kinetics; D008970:Molecular Weight; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits
D002860:Chromium Radioisotopes; D006025:Glycosaminoglycans; D003871:Dermatan Sulfate; D006493:Heparin; D003094:Collagen